(312) 275-5850 9-5pm CST
0 CART $0.00
Your shopping cart is empty.
CIA Medical Google Customer Reviews – Central Infusion Alliance
CIA Medical BBB Accredited A+ Business – Central Infusion Alliance
CIA Medical Digicert EV Secure – Central Infusion Alliance
Menu

Edwards Lifesciences 151F7 - CATHETER, FEMORAL, VEIN INSERT, 7FR, SWN-GNZ, EACH

Edwards Lifesciences # 151F7 - CATHETER, FEMORAL, VEIN INSERT, 7FR, SWN-GNZ, EACH
Part Number Edwards Lifesciences 151F7
SKU Number CIA2231716
Sell Unit EACH
Ships Within 24 Hours
List Price $485.76
Enter a valid quantity
Product Description

Edwards Lifesciences 151F7 - CATHETER, FEMORAL, VEIN INSERT, 7FR, SWN-GNZ, EACH

Swan-Ganz catheter

Continuous view of cardiac function in your most complex patients

The first flow-directed Swan-Ganz pulmonary artery catheter revolutionized hemodynamic monitoring in critically ill patients.By providing a comprehensive hemodynamic profile, utilizing continuous data, Swan-Ganz pulmonary artery catheters track your patients hemodynamic status to assist your early evaluation.

Swan-Ganz advanced technology pulmonary artery catheters enable continuous assessment of flow, pressure, and oxygen delivery and consumption, so you have an uninterrupted view of cardiac function for proactive decisions support in your most complex patients.

Target complex patient conditions with advanced hemodynamic parameters

Swan-Ganz catheter allows continuous monitoring of the balance of oxygen delivery and consumption with these advanced hemodynamic parameters:

  • Mixed venous oxygen saturation (SvO2)
  • Cardiac output (CO)
  • Stroke volume (SV)
  • Systemic vascular resistance (SVR)
  • Right ventricular ejection fraction (RVEF)
  • Right ventricular end diastolic volume (RVEDV)
  • Pulmonary artery pressure (PAP)
  • Pulmonary artery occlusion pressure (PAOP)

SvO2mixed venous oxygen saturation

Swan-Ganz pulmonary artery catheters provide continuous monitoring of SvO2. Since SvO2is a sensitive indicator of the patients status and generally precedes other indications of cardiopulmonary instability, continuous SvO2monitoring may allow diagnostic and therapeutic decisions to be made earlier in the patient's clinical course.